Prophylactic HIV Vaccines: Where Are We?

Prophylactic HIV Vaccines: Where Are We? 7/23/2007
International AIDS Society and Australasian Society for HIV Medicine, Sydney, Australia

Subscribe to Podcasts from IAS 2007

Kaiser Daily HIV/AIDS Reports on HIV/AIDS Vaccines

For more information on this session, please see the conference Programme-at-a-Glance page.

Full version:

Video

Podcast

Transcript

Speakers for this session:

Chairpersons

Jose Esparza, M.D., Ph.D.
Senior Advisor on HIV Vaccines, HIV, TB, and Reproductive Health
The Bill and Melinda Gates Foundation
United States
Keith Peden, Ph.D.
Center for Biologics Evaluation and Research, FDA
United States

Video

Phase IIB HIV Vaccine Trials and Viral Load Endpoints

Glenda Gray, M.D.

Co-founder and Co-Director

Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital

South Africa

Video |

Slides

Neutralizing Antibodies

Denis Burton, Ph.D.

Professor of Immunology and Molecular Biology

The Scripps Research Institute

United States

Video

Vector Based Vaccines

Guiseppe Pantaleo, M.D.
Professor of Medicine
Chief, Division of Immunology and Allergy, University of Lausanne

Switzerland

Video |

Slides

Correlates of Immunity

Bruce D. Walker, M.D.

Professor of Medicine, Harvard Medical School

Director, Partners AIDS Research Center, Massachusetts General Hospital

United States

Video

EMAIL ALERTS
Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.

FAQs

More...

CONTACT US
Contact us by email with any comments, problems, suggestions.
Call the kaisernetwork.org Help Desk at 202-347-5270.

...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ......